UC San Diego researchers developed an AI tool that accurately predicts colorectal cancer risk in ulcerative colitis patients using clinical and imaging data.
Key Details
- 1AI workflow reviewed records of 55,000 patients in the VA health care system, the largest US dataset of its kind.
- 2Combined large language models and statistical risk models to predict progression from low-grade dysplasia to cancer.
- 3Classified patients into five risk groups based on lesion size, number, visibility, resection completeness, and inflammation severity.
- 4Nearly half of patients were categorized as lowest risk, with the model correctly predicting 99% would not develop cancer within two years.
- 5The tool matched real-world outcomes for over ten years of follow-up data.
- 6The model may allow some low-risk patients to have less frequent surveillance colonoscopies.
Why It Matters
This AI system offers more precise, data-driven cancer risk assessments for clinicians, potentially reducing unnecessary procedures and focusing attention on high-risk patients, improving both care quality and resource allocation in gastrointestinal oncology.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.